Significant correlation between clinical factors and functional brain connectivity measures. حسب Chang Min Heo (11994905)

Results of the mediation model test for the elevated inhibition function in the relationship between elevated mindfulness level and decreased mobile phone addiction index. حسب Jizhao Li (5856650)

Figure 2 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Figure 4 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Figure 3 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Table S2 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Table S6 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Figure 1 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Table S5 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Clinical parameters and their significance among dengue severity. حسب Najeeha Talat Iqbal (9248912)

الموضوعات:

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

"…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

"…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

"…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"

Average mean decrease Gini across 100 partitions for the top 10 most important variables for binary mixed model and random forest. حسب Helal El-Zaatari (20442243)

Downregulation of <i>TcPiezo1</i> expression decreases Ca²⁺ entry in <i>T. cruzi.</i> حسب Guozhong Huang (673424)

"…(B) Downregulation of <i>TcPiezo1</i> expression showed a significant decrease of intracellular Ca²⁺ (+Tet). …"

FK506 significantly potentiates caspofungin activity against tolerant <i>C. tropicalis</i> strains, reversing tolerance phenotypes in both <i>in vitro</i> and <i>in vivo</i> models... حسب Yongqin Wu (272012)

الموضوعات:

IKK KO in microglia leads to increased accumulation of PK-resistant PrP <i>in vitro</i> but decreased accumulation <i>in vivo.</i> حسب Arielle J. D. Hay (15456341)

Clinical data of the control and CoA cases in our cohort. حسب Inmaculada Villanueva-Baxarias (21454246)

الموضوعات:

Proviral load in blood was decreased in HTLV-1 infected CD133+ Hu-mice when vCTCF-BS was deleted. حسب Ancy Joseph (5634794)

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. حسب Jelena Filimonovic (22305307)

الموضوعات: